09.12.12
Providence, R.I.-based medical device manufacturer Ximedica has appointed a new board member. Geoff Tuff is a partner at Monitor, a company that partners with other firms to help them grow. He serves as a leader of Monitor’s innovation practice.
“Geoff’s focus has been in helping clients drive profitable top-line growth,” said Randall Barko, CEO of Ximedica. “The nature of his work spans the domains of corporate strategy, product strategy development and execution, organizational structure, training and tools. His involvement will help facilitate our efforts to continuously improve Ximedica’s offering to the medical device, drug delivery and consumer healthcare clients which we serve globally.”
Tuff brings almost 20 years of experience at Monitor working in a wide range of industries that include pharmaceuticals, medical devices and consumer products, making him an apt fit for Ximedica’s board. He recently co-authored an article in the Harvard Business Review in which he discusses how successful companies must achieve total innovation. The path to such, according to Tuff’s article, means the need to strike “the right balance of core, adjacent, and transformational initiatives across the enterprise, and have put in the place the tools and capabilities to manage those various initiatives as parts of an integrated whole.”
Tuff earned his B.A. with honors from Dartmouth College in Hanover, N.H., and holds an M.B.A. from Harvard Business School in Cambridge, Mass. Throughout his career, he has developed some of Monitor’s core methodologies related to driving top-line growth for clients, and currently is an account manager for several of the Cambridge-based firm’s leading clients.
Barko added, “Geoff’s innovative ideology brings solid business sense to Ximedica’s core abilities to provide an integrated solution from insight to outcome. We look forward to Geoff’s contributions as we continue our pursuit to become the premier outsourced medical product development solution provider to the healthcare industry.”
Outside Providence, Ximedica also has offices in Minnesota and Hong Kong. The company provides integrated human-centered research, product development, regulatory, and new product introduction manufacturing services to medical device and healthcare companies. Ximedica is ISO 13485:2003 certified and U.S. Food and Drug Administration-registered.
“Geoff’s focus has been in helping clients drive profitable top-line growth,” said Randall Barko, CEO of Ximedica. “The nature of his work spans the domains of corporate strategy, product strategy development and execution, organizational structure, training and tools. His involvement will help facilitate our efforts to continuously improve Ximedica’s offering to the medical device, drug delivery and consumer healthcare clients which we serve globally.”
Tuff brings almost 20 years of experience at Monitor working in a wide range of industries that include pharmaceuticals, medical devices and consumer products, making him an apt fit for Ximedica’s board. He recently co-authored an article in the Harvard Business Review in which he discusses how successful companies must achieve total innovation. The path to such, according to Tuff’s article, means the need to strike “the right balance of core, adjacent, and transformational initiatives across the enterprise, and have put in the place the tools and capabilities to manage those various initiatives as parts of an integrated whole.”
Tuff earned his B.A. with honors from Dartmouth College in Hanover, N.H., and holds an M.B.A. from Harvard Business School in Cambridge, Mass. Throughout his career, he has developed some of Monitor’s core methodologies related to driving top-line growth for clients, and currently is an account manager for several of the Cambridge-based firm’s leading clients.
Barko added, “Geoff’s innovative ideology brings solid business sense to Ximedica’s core abilities to provide an integrated solution from insight to outcome. We look forward to Geoff’s contributions as we continue our pursuit to become the premier outsourced medical product development solution provider to the healthcare industry.”
Outside Providence, Ximedica also has offices in Minnesota and Hong Kong. The company provides integrated human-centered research, product development, regulatory, and new product introduction manufacturing services to medical device and healthcare companies. Ximedica is ISO 13485:2003 certified and U.S. Food and Drug Administration-registered.